Search - tctmd.com

Displaying 141 - 160 of 1715

Sort: Relevancy | Date

Presentation TCT 2024

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

Presenter: Jiasheng Yin

October 27, 2024

Presentation TCT 2024

TCT 1408: Pentafurcation of LAD Treated With Drug Eluting Baloom

Presenter: Mahpaekar Mashhadi

October 27, 2024

Presentation TCT 2024

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

Presenter: Matthias Lutz

October 27, 2024

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Presenter: Haibo Jia

October 26, 2023

Presentation TCT 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Presenter: Tobias Koch

October 26, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon

Presenter: Matthias Bossard

October 26, 2023

Presentation TCT 2023

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

Presenter: Alessandra Laricchia

October 26, 2023

Presentation TCT 2023

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Presenter: Ae-Young Her

October 26, 2023

Presentation TCT 2023

Novel Solutions for High Bleeding Risk Patients

Presenter: Bjorn Redfors

October 26, 2023

Presentation TCT 2023

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

Presenter: Matthew Li Kam Wa

October 26, 2023

Presentation TCT 2023

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

Presenter: Jun-Won Lee

October 26, 2023

Presentation TCT 2023

TCT 52: Coronary Bifurcation Bench to Assess the Impact of Stent Strut Link Location in Proximal Balloon Edge Dilation Technique

Presenter: Teruyoshi Kume

October 26, 2023

Presentation TCT 2023

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Presenter: Stephan Windecker

October 26, 2023

Presentation TCT 2023

DES to Allow Adaptive Remodeling

Presenter: Daniel Chamie

October 26, 2023

Presentation TCT 2023

The Modern Era of Ultra-Thin Struts – Is It a True Advantage?

Presenter: Robert Stoler

October 26, 2023

Advertisement

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

TCT 1408: Pentafurcation of LAD Treated With Drug Eluting Baloom

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Novel Solutions for High Bleeding Risk Patients

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

TCT 52: Coronary Bifurcation Bench to Assess the Impact of Stent Strut Link Location in Proximal Balloon Edge Dilation Technique

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

DES to Allow Adaptive Remodeling

The Modern Era of Ultra-Thin Struts – Is It a True Advantage?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content